Maryland is the first state to tap into an old fund connected to the Affordable Care Act to help solve a new problem: helping pay the expenses of patients who travel to Maryland for an abortion. With abortion now restricted or illegal in 22 states, jurisdictions like Maryland have become a destination for patients from…
Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a month — when they shop for next year’s coverage. Such drug plans are used by millions of people who enroll in what is called original Medicare, the classic federal government program that began…
A group of healthcare organizations sent a letter to Congressional leaders urging them to permanently extend Medicare telehealth flexibilities introduced during the Covid-19 pandemic. The post 350 Healthcare Organizations Call for Extension of Medicare Telehealth Access appeared first on MedCity News.
Isaac Health, a startup specializing in cognitive care for Alzheimer’s dementia , raised $10.5 million in Series A funding to expand nationwide access to its platform. The company partners with health plans to provide screening, specialist diagnosis, treatment, and ongoing management aimed at slowing cognitive decline. The post Isaac Health Raises $10.5M for its Specialist-Led…
KFF is tracking the Medicaid provisions in the 2025 federal budget bill, including new Medicaid work and verification requirements and a reduction in the expansion match rate for states that use their own funds to cover undocumented immigrants.
The OIG has released a review of the VHA’s staffing shortages for 2025
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” The federal government will stockpile active pharmaceutical ingredients for these products, which the administration contends will insulate the U.S. from foreign supplies while also encouraging more domestic API production. The post Trump’s Push for U.S. Drug Manufacturing…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
On July 31, President Trump sent letters to some of the largest pharmaceutical companies in the world (AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi) asking them to fundamentally change drug pricing in the US. What was…
Richard Clarke, Ph.D., Highmark’s chief analytics officer, says AI solution will help clinicians understand in real-time whether they have inadequate evidence for a prior authorization